Growth Metrics

Nutex Health (NUTX) Depreciation Expense (2016 - 2017)

Nutex Health's Depreciation Expense history spans 5 years, with the latest figure at $213.0 for Q1 2017.

  • For Q1 2017, Depreciation Expense rose 80.51% year-over-year to $213.0; the TTM value through Mar 2017 reached $568.0, up 207.98%, while the annual FY2016 figure was $473.0, 28.55% down from the prior year.
  • Depreciation Expense for Q1 2017 was $213.0 at Nutex Health, up from -$16723.0 in the prior quarter.
  • Across five years, Depreciation Expense topped out at $12505.0 in Q2 2016 and bottomed at -$16723.0 in Q4 2016.
  • The 5-year median for Depreciation Expense is $1191.0 (2014), against an average of $534.0.
  • The largest YoY upside for Depreciation Expense was 2671.52% in 2016 against a maximum downside of 10174.1% in 2016.
  • A 5-year view of Depreciation Expense shows it stood at $1673.0 in 2013, then decreased by 28.75% to $1192.0 in 2014, then crashed by 86.07% to $166.0 in 2015, then crashed by 10174.1% to -$16723.0 in 2016, then soared by 101.27% to $213.0 in 2017.
  • Per Business Quant, the three most recent readings for NUTX's Depreciation Expense are $213.0 (Q1 2017), -$16723.0 (Q4 2016), and $4573.0 (Q3 2016).